Logo image of AVTR

AVANTOR INC (AVTR) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:AVTR - US05352A1007 - Common Stock

10.75 USD
-0.18 (-1.65%)
Last: 12/8/2025, 3:58:08 PM

AVTR Key Statistics, Chart & Performance

Key Statistics
Market Cap7.33B
Revenue(TTM)6.58B
Net Income(TTM)-82.20M
Shares681.81M
Float657.58M
52 Week High23.32
52 Week Low10.83
Yearly Dividend0
Dividend YieldN/A
EPS(TTM)0.96
PE11.2
Fwd PE11.66
Earnings (Next)02-05 2026-02-05/amc
IPO2019-05-17
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


AVTR short term performance overview.The bars show the price performance of AVTR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

AVTR long term performance overview.The bars show the price performance of AVTR in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of AVTR is 10.75 USD. In the past month the price decreased by -3.45%. In the past year, price decreased by -48.9%.

AVANTOR INC / AVTR Daily stock chart

AVTR Latest News, Press Relases and Analysis

AVTR Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.34 213.27B
DHR DANAHER CORP 29.1 158.47B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 186.35 56.63B
A AGILENT TECHNOLOGIES INC 25.52 40.37B
IQV IQVIA HOLDINGS INC 19.24 38.10B
MTD METTLER-TOLEDO INTERNATIONAL 33.07 28.26B
WAT WATERS CORP 30.89 23.35B
WST WEST PHARMACEUTICAL SERVICES 38.03 19.34B
ILMN ILLUMINA INC 29.2 19.45B
MEDP MEDPACE HOLDINGS INC 38.4 15.47B
TEM TEMPUS AI INC N/A 13.69B
RVTY REVVITY INC 20.79 11.29B

About AVTR

Company Profile

AVTR logo image Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Company Info

AVANTOR INC

Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road

Radnor PENNSYLVANIA 19087 US

CEO: Michael Stubblefield

Employees: 13500

AVTR Company Website

AVTR Investor Relations

Phone: 16103861700

AVANTOR INC / AVTR FAQ

What does AVANTOR INC do?

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.


Can you provide the latest stock price for AVANTOR INC?

The current stock price of AVTR is 10.75 USD. The price decreased by -1.65% in the last trading session.


Does AVANTOR INC pay dividends?

AVTR does not pay a dividend.


What is the ChartMill rating of AVANTOR INC stock?

AVTR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What do analysts say about AVANTOR INC (AVTR) stock?

26 analysts have analysed AVTR and the average price target is 13.84 USD. This implies a price increase of 28.76% is expected in the next year compared to the current price of 10.75.


Is AVANTOR INC (AVTR) expected to grow?

The Revenue of AVANTOR INC (AVTR) is expected to decline by -4.16% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the employee count for AVTR stock?

AVANTOR INC (AVTR) currently has 13500 employees.


AVTR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AVTR Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AVTR. While AVTR is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVTR Financial Highlights

Over the last trailing twelve months AVTR reported a non-GAAP Earnings per Share(EPS) of 0.96. The EPS decreased by -2.04% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.7%
ROE -1.48%
Debt/Equity 0.65
Chartmill High Growth Momentum
EPS Q2Q%-15.38%
Sales Q2Q%-5.28%
EPS 1Y (TTM)-2.04%
Revenue 1Y (TTM)-3.59%

AVTR Forecast & Estimates

26 analysts have analysed AVTR and the average price target is 13.84 USD. This implies a price increase of 28.76% is expected in the next year compared to the current price of 10.75.

For the next year, analysts expect an EPS growth of -8.14% and a revenue growth -4.16% for AVTR


Analysts
Analysts70.77
Price Target13.84 (28.74%)
EPS Next Y-8.14%
Revenue Next Year-4.16%

AVTR Ownership

Ownership
Inst Owners100.14%
Ins Owners0.3%
Short Float %3.89%
Short Ratio2.4